Incruse Ellipta powder for inhalation
Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
Summary of Product characteristics
(SPC)
20-12-2016
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
umeclidinium (umeclidinium bromide)
Available from:
Glaxo Operations UK Ltd
ATC code:
R03BB07
INN (International Name):
umeclidinium (umeclidinium bromide)
Dosage:
62.5mcg/dose
Pharmaceutical form:
powder for inhalation
Units in package:
powder in strip (30 doses) in plastic inhaler
Prescription type:
Prescription
Authorization status:
Registered
Authorization date:
2016-12-19
